BIRADS III lesion
Citation, DOI, disclosures and case data
At the time the case was submitted for publication Paresh K Desai had no recorded disclosures.View Paresh K Desai's current disclosures
Loading Stack -
0 images remaining
A smooth well-defined lesion is seen in the right breast.
Uniformly hypoechoic, transverse diameter > AP, posterior accoustic enhancement, no micro/ macrocalcifications.
All features are consistent with a probable benign lesion (BIRADS III).
BI-RADS 3 carries a management recommendation of short-term follow-up. The recommendation should be for the modality or modalities that best demonstrated the initial finding.
While follow-up protocols differ across practices, a common schedule is at 6, 12, and 24 months. Once stability is documented for at least two, and at most three, years, the finding can be downgraded to BI-RADS 2 (benign). If the finding develops suspicious features, such as growth, non-circumscribed margins, or suspicious calcification morphology, then it should be upgraded to BI-RADS 4 or 5.